Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
Mais filtros

País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
2.
Ann R Coll Surg Engl ; 104(5): 356-360, 2022 May.
Artigo em Inglês | MEDLINE | ID: mdl-34981994

RESUMO

INTRODUCTION: This paper assessed the association between operative approach and postoperative in-hospital mortality in elderly patients undergoing emergency abdominal surgery. Patients undergoing emergency laparotomy have high morbidity and mortality rates. One-third of patients requiring emergency surgery are over 75 years old, and their in-hospital mortality rate exceeds 17%. Fewer than 20% of emergency abdominal operations in the UK are attempted laparoscopically, and only 10% are completed laparoscopically. Little is known about how laparoscopic emergency surgery in the elderly might affect outcomes. METHODS: An observational UK study was performed using the prospectively maintained National Emergency Laparotomy Audit (NELA) database. Operative approach, NELA risk-prediction score and in-hospital mortality were recorded. The effect of operative approach on in-hospital mortality was analysed, both on a national basis and in a high-volume laparoscopic centre. RESULTS: A total of 47,667 patients were included in the study, of whom 15,068 were over 75 years of age. Nationally, surgery was completed by the laparoscopic approach in 7.8% of patients aged over 75; both crude mortality (9.2%) and risk-adjusted mortality (7.1%) were significantly reduced (p<0.0001). In our unit, surgery was completed laparoscopically in 48.4% of patients aged over 75; both crude mortality (6.6%) and risk-adjusted mortality (3.3%) were significantly reduced (p<0.0001). CONCLUSION: Laparoscopy in emergency surgery has been shown in this study to significantly reduce in-hospital mortality in elderly patients and should be embraced in every centre dealing with emergency abdominal surgery.


Assuntos
Laparoscopia , Laparotomia , Idoso , Bases de Dados Factuais , Mortalidade Hospitalar , Humanos , Laparoscopia/efeitos adversos , Laparotomia/efeitos adversos , Estudos Retrospectivos , Fatores de Risco
3.
Ann R Coll Surg Engl ; 103(3): 180-185, 2021 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-33645274

RESUMO

INTRODUCTION: The UK has an ageing population with an increased prevalence of frailty in the over 70s. Emergency laparotomy for acute intra-abdominal pathology is increasingly offered to this population. This can challenge decision making and information given to patients should not only be based on mortality outcomes but on relative expected quality of life and change to frailty syndromes. MATERIALS AND METHODS: This was a single site National Emergency Laparotomy Audit (NELA)-based retrospective cohort audit for consecutive cases in the septuagenarian population assessing mortality, length of stay outcome and subjective postoperative functioning. Follow-up was conducted between one and two years postoperatively to determine this. RESULTS: Some 153 patients were identified throughout the single site NELA database. Median age was 79 years with a ratio of 1.7 men to women. Median rate of all-cause mortality was 35.3% at the median follow-up of 19 months. Median time from admission to death was 120 days. Of those who had died by the time of follow-up, significant preoperative indicators included clinical frailty scale (p < 0.0001), preoperative P-POSSUM (mortality). At follow-up, 35% responded to a quality of life follow-up. This revealed a decline in mid-term physical functioning, lower energy, higher fatigue and reduction in social functioning. There was also an increase in pre- and postoperative clinical frailty scale score. CONCLUSION: In the septuagenarian-plus population it is important to consider not only risk stratification with mortality scoring (P-POSSUM or NELA-adjusted risk), but to take into account frailty. Postoperative rehabilitation and careful recovery is paramount. Where possible, during the counselling and consent for emergency laparotomy, significant postoperative long-term deterioration in physical, emotional and social function should be considered.


Assuntos
Emergências , Fragilidade/epidemiologia , Estado Funcional , Mortalidade Hospitalar , Laparoscopia , Laparotomia , Tempo de Internação , Qualidade de Vida , Idoso , Idoso de 80 Anos ou mais , Estudos de Coortes , Fadiga , Feminino , Seguimentos , Idoso Fragilizado , Humanos , Masculino , Estudos Retrospectivos , Interação Social , Reino Unido/epidemiologia
4.
Dig Surg ; 27(5): 367-74, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20938180

RESUMO

AIMS: To evaluate the role of the Physiological and Operative Severity Score for the enUmeration of Mortality and Morbidity (POSSUM), the Portsmouth variant (p-POSSUM) and the Glasgow Prognostic Score (GPS) in predicting outcome after pancreatic surgery with reference to the International Study Group of Pancreatic Surgery (ISGPS) definitions of post-pancreatectomy complications. METHODS: All consecutive patients undergoing major pancreatic resection over a 32- month period were included. POSSUM, p-POSSUM and GPS score were calculated for each patient and correlated against the observed mortality and morbidity using the ISGPS definitions. RESULTS: The observed:expected ratios for POSSUM mortality, POSSUM morbidity and p-POSSUM mortality were 0.24 (p < 0.0001), 0.86 (p < 0.0001) and 0.79 (p = 0.09), respectively. POSSUM had a 'poor fit' with respect to predicting morbidity (χ(2) = 16.4, 8 d.f., p = 0.04). Multifactorial regression analysis revealed the GPS as an independent predictor of post-operative outcome (GPS 1, p = 0.03, OR 2.99, 95% CI 1.4-7.9, and GPS 2, p = 0.02, OR 4.3, 95% CI 1.8-15.5). CONCLUSION: POSSUM has a limited role as an outcome score in pancreatic resection. The GPS may be a novel alternative to POSSUM as a pre-operative predictor of outcome.


Assuntos
Esvaziamento Gástrico/fisiologia , Pancreatectomia/efeitos adversos , Fístula Pancreática/epidemiologia , Pancreaticoduodenectomia/efeitos adversos , Hemorragia Pós-Operatória/epidemiologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Mortalidade Hospitalar , Humanos , Masculino , Pessoa de Meia-Idade , Pancreatectomia/mortalidade , Pancreaticoduodenectomia/mortalidade , Complicações Pós-Operatórias/epidemiologia , Valor Preditivo dos Testes , Curva ROC , Análise de Regressão , Medição de Risco , Índice de Gravidade de Doença , Taxa de Sobrevida , Resultado do Tratamento , Adulto Jovem
5.
Eur J Vasc Endovasc Surg ; 37(2): 140-8, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19041268

RESUMO

Our report encompasses two cases of Dacron patch infection following carotid endarterectomy and a systematic review of the literature. Particular attention is placed on the incidence, aetiology, investigation, presentation and management dilemmas of this rare complication of carotid surgery. We present all known cases of synthetic patch infection following carotid endarterectomy over the last 12 years. 14 publications have been identified totalling 77 cases of graft infection. Approximately 0.25-0.5% of all Dacron patches appear to get infected. Infection may present early or late and appears to have a bi-modal distribution depending on the presence of low- or high-grade infection. Post-operative complications especially wound haematoma is associated with the later development of infection. Most patients present with pseudoaneurysm formation, neck swelling or a draining local sinus and are infected with either Staphylococcus epidermidis or Staphylococcus aureus. Duplex ultrasound is the investigation of choice and complete excision of all infected material and arterial reconstruction with a vein patch or graft is recommended. Dacron patch infection is a rare but recognised complication of carotid surgery and knowledge of this condition is vital for vascular surgeons and other speciality surgeons to whom cases may present.


Assuntos
Implante de Prótese Vascular/efeitos adversos , Prótese Vascular/efeitos adversos , Estenose das Carótidas/cirurgia , Endarterectomia das Carótidas/efeitos adversos , Polietilenotereftalatos , Infecções Relacionadas à Prótese/etiologia , Idoso , Idoso de 80 Anos ou mais , Implante de Prótese Vascular/instrumentação , Remoção de Dispositivo , Endarterectomia das Carótidas/instrumentação , Feminino , Humanos , Incidência , Masculino , Desenho de Prótese , Infecções Relacionadas à Prótese/diagnóstico por imagem , Infecções Relacionadas à Prótese/microbiologia , Infecções Relacionadas à Prótese/cirurgia , Reoperação , Fatores de Risco , Resultado do Tratamento , Ultrassonografia
6.
Ann R Coll Surg Engl ; 100(4): 279-284, 2018 04.
Artigo em Inglês | MEDLINE | ID: mdl-29364016

RESUMO

Background Acute abdominal pathology requiring emergency laparotomy is a common surgical presentation. Despite its widespread implementation in other surgical procedures, laparoscopy, rather than laparotomy, is sparingly used in major emergency surgery. This study reports outcomes and impact of rising use of laparoscopy for a single high-volume district general hospital. Methods Data were retrieved from the prospective National Emergency Laparotomy Audit database for a 30-month period. Patient, procedural, and in-hospital outcome data were collated. Temporal trends were assessed and regression analysis conducted for clinical outcomes. Results A total of 748 consecutive cases were recorded. There was an increasing use of laparoscopy over the study period, with 49% of cases attempted laparoscopically in the final six-month interval. Patients treated laparoscopically were at reduced risk of mortality (odds ratio 0.114, 95% confidence interval 0.024 to 0.550) and experienced reduced length of intensive care stay (regression coefficient ­1.571, 95% confidence interval ­2.625 to ­0.517) in multivariate adjusted analysis. Conclusions Laparoscopy is safe and feasible in a large proportion of cases. It is associated with improved outcomes versus laparotomy.


Assuntos
Abdome Agudo/cirurgia , Serviços Médicos de Emergência/estatística & dados numéricos , Laparoscopia/estatística & dados numéricos , Adulto , Idoso , Idoso de 80 Anos ou mais , Serviços Médicos de Emergência/métodos , Serviços Médicos de Emergência/normas , Serviços Médicos de Emergência/tendências , Estudos de Viabilidade , Feminino , Mortalidade Hospitalar , Humanos , Unidades de Terapia Intensiva/estatística & dados numéricos , Laparoscopia/métodos , Laparoscopia/mortalidade , Laparoscopia/tendências , Tempo de Internação/estatística & dados numéricos , Masculino , Pessoa de Meia-Idade , Guias de Prática Clínica como Assunto , Estudos Prospectivos , Resultado do Tratamento , Adulto Jovem
7.
J Neuroimmunol ; 179(1-2): 126-31, 2006 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16934877

RESUMO

PURPOSE: To investigate changes in immune response genes following Toxoplasma gondii infection of Müller cells. METHODS: Human Müller cells were infected or mock infected with two strains of T. gondii (RH and Prugniaud). RNA and supernatants were collected from infected and uninfected cells at 2 and 24 h. RNA from the two time points were compared using a custom made DNA microarray. Real time PCR or human cytokine antibody array was used to confirm up-regulation of immune molecules. RESULTS: Gene expression in infected cells showed up-regulation of CCL2, IL-6, CXCL8, and CXCL2. CCL2 and CXCL2 gene expression was confirmed by real time PCR. IL-6 and CXCL8 protein production was confirmed by a cytokine antibody array. IL-4 production was observed by cytokine antibody array but not by DNA microarray. In contrast, infection with T. gondii did not induce interferon-gamma (IFNgamma) and IL-12 expression, molecules conventionally associated with the inter-conversion of tachyzoite to bradyzoite. CONCLUSION: These results indicate that while in vitro infected Müller cells may be capable of inducing an immune response by attracting blood-borne leucocytes, they do not appear able to directly control the proliferation of T. gondii.


Assuntos
Expressão Gênica/imunologia , Genes MHC da Classe II/fisiologia , Toxoplasmose/imunologia , Animais , Linhagem Celular , Citocinas/metabolismo , Perfilação da Expressão Gênica , Humanos , Análise de Sequência com Séries de Oligonucleotídeos , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Toxoplasma/imunologia
8.
J Neuroimmunol ; 160(1-2): 41-7, 2005 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15710456

RESUMO

Cells infected by Toxoplasma gondii undergo up-regulation of proinflammatory cytokines, organelle redistribution, and protection from apoptosis. During infection in man, the parasite encysts within the retina, a process that results in retinochoroiditis which can lead to permanent loss of sight. The reasons for the parasite to infect retinal tissue and the mechanisms by which it encysts are not clearly understood. We studied the effect of infection with T. gondii of retinal vascular endothelial cells using the Clontech Atlastrade mark array system in order to elucidate changes in gene expression. We compared hybridization of RNA to the array from infected and uninfected cells at two time points; 2 and 24 h. Exposure to T. gondii after 2 h resulted in change of expression of approximately 6% of genes on the array, including those involved in cell structure, protein and vesicle trafficking, cell-cycle regulation, transcriptional and translational machinery, and apoptosis. Among the genes involved in the inflammatory response, chemokine genes such as GRO1 (Growth Regulated Oncogene 1), MCP-1 (Monocyte Chemotactic Protein-1), FKN (Fractalkine) and RANTES (Regulated upon Activation, Normal T Cell Expressed and Secreted) were found to be up-regulated and protein production was confirmed by ELISA. However after 24 h of infection, GRO1, MCP-1 and FKN were down-regulated, confirmed by RT-PCR. Thus, invasion of retinal vascular endothelium (RVE) cells by T. gondii leads to the production of chemokines important in directing the traffic of inflammatory cells to the infected area.


Assuntos
Quimiocinas/biossíntese , Endotélio Vascular/imunologia , Endotélio Vascular/parasitologia , Vasos Retinianos/imunologia , Vasos Retinianos/parasitologia , Toxoplasma/imunologia , Animais , Linhagem Celular Transformada , Quimiocina CCL2/biossíntese , Quimiocina CCL2/genética , Quimiocina CCL5/biossíntese , Quimiocina CCL5/genética , Quimiocina CX3CL1 , Quimiocina CXCL1 , Quimiocinas/genética , Quimiocinas CX3C/biossíntese , Quimiocinas CX3C/genética , Quimiocinas CXC/biossíntese , Quimiocinas CXC/genética , Endotélio Vascular/metabolismo , Ensaio de Imunoadsorção Enzimática , Perfilação da Expressão Gênica , Peptídeos e Proteínas de Sinalização Intercelular/biossíntese , Peptídeos e Proteínas de Sinalização Intercelular/genética , Proteínas de Membrana/biossíntese , Proteínas de Membrana/genética , Análise de Sequência com Séries de Oligonucleotídeos/métodos , RNA Mensageiro/genética , Ratos , Vasos Retinianos/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Regulação para Cima/imunologia
9.
Vet Parasitol ; 130(3-4): 207-12, 2005 Jun 30.
Artigo em Inglês | MEDLINE | ID: mdl-15925723

RESUMO

A commercially available ELISA for detecting antibodies to liver fluke was evaluated for use in Australia. Milk and serum samples from cattle and sheep in which infection with Fasciola hepatica was confirmed by detection of eggs in faeces were used to estimate sensitivity. Similar samples collected from cattle and sheep outside the F. hepatica-endemic area were used to estimate specificity. The ELISA was also evaluated for detecting antibodies to F. hepatica in milk from sheep and antibodies to Fasciola gigantica in sera from cattle and buffaloes, but with small numbers of samples. In cattle, the sensitivity and specificity of the ELISA were 98.2% and 98.3% using serum and 97.7% and 99.3% using milk. In infected herds, 41.4% and 41.5% of animals were positive in the serum and milk ELISAs, respectively, whereas F. hepatica eggs were found in faecal samples from 26.5% of animals. In sheep, the sensitivity of the ELISA was 96.9% and the specificity was 99.4%. In infected flocks, 60.2% of animals were positive in the serum ELISA and F. hepatica eggs were found in faecal samples 52.2% of animals. There was perfect agreement in the ELISA between paired serum and milk samples collected from ewes. The assay detected antibodies in sera from cattle and buffaloes with natural and experimental F. gigantica infections. In the experimentally infected animals, antibodies were detected 2 weeks post-infection. We conclude that the ELISA will be a valuable tool for diagnosing F. hepatica infections in cattle and sheep. The assay may also be useful for diagnosing F. gigantica infections but further studies are required to establish sensitivity and specificity.


Assuntos
Anticorpos Anti-Helmínticos/análise , Búfalos/parasitologia , Doenças dos Bovinos/diagnóstico , Fasciolíase/veterinária , Doenças dos Ovinos/diagnóstico , Animais , Austrália , Bovinos , Doenças dos Bovinos/parasitologia , Ensaio de Imunoadsorção Enzimática/veterinária , Fasciolíase/diagnóstico , Fezes/parasitologia , Leite/química , Contagem de Ovos de Parasitas/veterinária , Sensibilidade e Especificidade , Ovinos , Doenças dos Ovinos/parasitologia , Fatores de Tempo
10.
Melanoma Res ; 6(4): 299-306, 1996 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-8873049

RESUMO

In an attempt to induce an immune response against tumour antigens, several groups are transfecting cytokine and other genes into autologous tumour cells which are given to the patient as a vaccine. This process is labour-intensive, time-consuming and expensive. Allogeneic cells would offer a more convenient vehicle for the delivery of cytokines and other molecules. However, current dogma suggests that MHC-matched cells are a prerequisite for an effective immune response. Using murine melanoma models we compared allogeneic and autologous vaccination and showed that the survival of C56BL/6 mice (H-2b) was prolonged with some degree of protection achieved against an autologous B15-F10 (H-2b) cell challenge when the mice were vaccinated with allogeneic K1735-M2 (H-2k) cells but not when immunized with autologous B16-F10 cells. Both vaccination with live and irradiated allogeneic cells induced an anti-tumour effect using only one immunization and no boost or adjuvant. Protection was not observed after vaccination with another melanoma (S91; H-2d) or with a carcinoma (A9HT; H-2k). Allogeneic vaccination promoted a cytotoxic cellular response against both the allogeneic and the syngeneic melanomas. This allogeneic vaccination model will be useful for studying the underlying mechanisms of protection, in both pre- and post-challenge settings, as well as for developing whole cell vaccination systems using genetically modified allogeneic tumour cells.


Assuntos
Vacinas Anticâncer/uso terapêutico , Melanoma Experimental/imunologia , Melanoma Experimental/prevenção & controle , Animais , Modelos Animais de Doenças , Feminino , Citometria de Fluxo , Antígenos de Histocompatibilidade Classe I/análise , Antígenos de Histocompatibilidade Classe II/análise , Humanos , Camundongos , Camundongos Endogâmicos C3H , Camundongos Endogâmicos C57BL , Células Tumorais Cultivadas/efeitos da radiação
11.
BMJ Case Rep ; 20112011 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-22707467

RESUMO

Anal gland carcinoma (AGC) is rare, and its innocuous presentation and developing immunohistochemical profile make the diagnosis of it challenging. Predominant presenting symptoms include anal pain, rectal bleeding and the presence of a perianal mass in advanced stages of the disease. Histological profile commonly reveals an intramural adenocarcinoma with normal unaffected overlying anorectal mucosa. Immunohistochemical analysis shows positive staining for cytokeratin (CK) 7 and negative staining for CK20. MUC5AC expression with CK5/6 and p53 negativity has been reported. The authors report a case of a 68-year-old woman with a rapidly advancing AGC and review the current literature with respect to diagnosis and current consensus on therapeutic management.


Assuntos
Canal Anal , Neoplasias do Ânus/patologia , Carcinoma/patologia , Idoso , Feminino , Humanos
12.
Biochem J ; 331 ( Pt 1): 161-7, 1998 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-9512475

RESUMO

The Sec61 complex is a central component of the endoplasmic reticulum (ER) translocation site. The complex consists of three subunits: Sec61alpha, Sec61beta and Sec61gamma, at least two of which (alpha and beta) are adjacent to nascent proteins during membrane insertion. Another component of the translocation machinery is the translocating chain-associating membrane (TRAM) protein, which is also adjacent to many nascent proteins during membrane insertion. Sec61alpha functions as the major component of a transmembrane channel formed by oligomers of the Sec61 complex. This channel is the site of secretory protein translocation and membrane protein integration at the ER membrane. Sec61alpha is a polytopic integral membrane protein, and we have studied its biosynthesis and membrane integration in vitro. Using a cross-linking approach to analyse the environment of a series of discrete Sec61alpha membrane-integration intermediates, we find: (i) newly synthesized Sec61alpha is adjacent to known components of the ER membrane-insertion site, namely Sec61alpha, Sec61beta and TRAM, and thus the integration of Sec61alpha appears to require a pre-existing Sec61 complex; (ii) a site-specific cross-linking analysis indicates that the first transmembrane domain of Sec61alpha remains adjacent to protein components of the ER-insertion site (specifically TRAM and Sec61beta) during the insertion of at least three subsequent transmembrane domains; and (iii) the membrane integration of Sec61alpha requires ER targeting by the signal-recognition particle.


Assuntos
Retículo Endoplasmático/metabolismo , Proteínas de Membrana/metabolismo , Microssomos/metabolismo , Pâncreas/metabolismo , Animais , Transporte Biológico , Reagentes de Ligações Cruzadas , Cães , Pâncreas/ultraestrutura , Canais de Translocação SEC
13.
Infect Immun ; 57(6): 1719-24, 1989 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-2656521

RESUMO

The capacity of various immunosuppressive agents to cause a recrudescence of the replication of Mycobacterium bovis BCG in the spleens of chronically infected mice was investigated. The actions of three corticosteroid preparations, cyclosporin A, and anti-T-cell subset monoclonal antibodies were compared. Treatment of mice with hydrocortisone acetate, which depressed the number of splenic lymphocytes and suppressed T-cell responses, most effectively exacerbated the stationary BCG counts, at 4 to 6 months after infection. The magnitude of reactivation was more pronounced in innately resistant CBA/Ca mice than in the susceptible C57BL/6 strain of mice. Splenic bacterial counts were also amplified by anti-L3T4 antibody when the antibody was injected at the chronic phase, whereas cyclosporin A had an effect only during the initial 6 weeks after BCG infection. Cultures of spleen cells from chronically infected mice showed a significant increase in the numbers of viable BCG recovered after 7 days of incubation in the presence of dexamethasone but not with cyclosporin A. The observed differences between the tested immunosuppressive agents indicate that the stationary bacterial counts during chronic BCG infection are maintained by discrete T-cell actions on the infected macrophages.


Assuntos
Mycobacterium bovis/crescimento & desenvolvimento , Tuberculose/microbiologia , Animais , Contagem de Colônia Microbiana , Ciclosporinas/administração & dosagem , Dexametasona/farmacologia , Feminino , Hidrocortisona/administração & dosagem , Hipersensibilidade Tardia/etiologia , Imunidade Inata , Depleção Linfocítica , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos CBA , Mycobacterium bovis/efeitos dos fármacos , Recidiva , Baço/microbiologia , Linfócitos T/classificação , Tuberculose/etiologia , Tuberculose/imunologia
14.
Clin Otolaryngol Allied Sci ; 27(5): 291-5, 2002 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-12383283

RESUMO

Tissue engineering is a multidisciplinary area of research aimed at regeneration of tissues and restoration of function of organs through implantation of cells/tissues grown outside the body or stimulating cells to grow into implanted matrix. In this short review, we aim to examine current techniques in gene expression analysis and their relevant clinical applications to the field of otorhinolaryngology-head and neck surgery.


Assuntos
Perfilação da Expressão Gênica , Neoplasias de Cabeça e Pescoço/genética , Otorrinolaringopatias/genética , Expressão Gênica/fisiologia , Técnicas Genéticas , Neoplasias de Cabeça e Pescoço/cirurgia , Humanos , Análise de Sequência com Séries de Oligonucleotídeos , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Engenharia Tecidual
15.
Ann Rheum Dis ; 51(2): 152-5, 1992 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-1550394

RESUMO

Fasting cholesterol, triglyceride, low density lipoprotein cholesterol, high density lipoprotein cholesterol, apoprotein AI, and apoprotein B were measured in 64 patients with systemic lupus erythematosus to assess the risk factors for vascular disease. The relation between the lipid profile, steroid treatment, the presence of anticardiolipin antibodies, and the prevalence of vascular disease was examined. Raised concentrations of triglyceride and apoprotein B were seen in those patients treated with more than the equivalent of 10 mg prednisolone a day in the six months before testing. An increase in vascular disease was found only in the subgroup of patients with increased triglycerides who also expressed anticardiolipin antibodies. This study confirms the association between treatment with high doses of steroids in lupus and the development of an atherogenic plasma lipid profile. The presence of anticardiolipin antibodies compounds the risk of developing vascular disease.


Assuntos
Autoanticorpos/análise , Cardiolipinas/imunologia , Jejum/sangue , Lipídeos/sangue , Lúpus Eritematoso Sistêmico/complicações , Doenças Vasculares/etiologia , Adulto , Idoso , Feminino , Humanos , Lúpus Eritematoso Sistêmico/sangue , Lúpus Eritematoso Sistêmico/imunologia , Masculino , Pessoa de Meia-Idade , Prednisolona/efeitos adversos , Prevalência , Fatores de Risco , Triglicerídeos/sangue , Doenças Vasculares/induzido quimicamente , Doenças Vasculares/epidemiologia
16.
Gene Ther ; 3(10): 853-8, 1996 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-8908498

RESUMO

The use of whole cell tumour vaccines in the treatment of malignant melanoma has given mixed results. Cytokine-transfected tumour cells as vaccine have shown efficacy in animal models but need to be compared with other means of enhancing a systemic anti-tumour immune response. A new generation of immunological adjuvants claimed to be more effective than the conventional adjuvants is now available for assessment. We have investigated the action of an oil-microemulsion adjuvant formulation (IDEC antigen formulation (IDEC-AF)) in the B16-F10 murine melanoma model. After standardisation of the whole cell tumour vaccination protocol we showed that mice vaccinated with whole irradiated cells combined with IDEC-AF produced a significant inhibition of tumour growth, following a challenge with live tumour cells, when compared with mice vaccinated with whole cell vaccine alone. IDEC-AF was superior to two conventional adjuvants, namely alum and incomplete Freund's adjuvant and a more reliable response was achieved with the oil-microemulsion adjuvant compared with IL-2-transfected cells. In addition, the adjuvant was comparable in efficacy to IL-4-transfected B16-F10 cells. Given the practical difficulty in using cytokine-transfected tumour cells and the limited therapeutic range of some cytokines, a cheap and easy to deliver adjuvant formulation proved equally or more effective than some of the currently clinically used transfected cytokines.


Assuntos
Vacinas Anticâncer/imunologia , Adjuvante de Freund/química , Interleucina-2/genética , Interleucina-4/genética , Melanoma/prevenção & controle , Vacinas de DNA/imunologia , Compostos de Alúmen , Animais , Linhagem Celular , Feminino , Adjuvante de Freund/toxicidade , Camundongos , Camundongos Endogâmicos C57BL , Óleos , Transfecção , Células Tumorais Cultivadas , Vacinação
18.
Bull. W.H.O. (Print) ; 6(1-2): 229-248, 1952.
Artigo em Inglês | WHOLIS | ID: who-266275
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA